The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preclinical and early clinical data of ZN-1041, a best-in-class BBB penetrable HER2 inhibitor to treat breast cancer with CNS metastases.
 
Fei Ma
Research Funding - Shanghai Escugen Biotechnology
 
Yiqun Li
No Relationships to Disclose
 
Herui Yao
No Relationships to Disclose
 
Jingfen Wang
No Relationships to Disclose
 
Quchang Ouyang
Research Funding - Beijing Biostar Technologies (Inst); Jiangsu Hengrui Pharmaceuticals (Inst)
 
Jing Cheng
No Relationships to Disclose
 
Xiaoyan Li
No Relationships to Disclose
 
Xiao-Xiao Dinglin
No Relationships to Disclose
 
Gongsheng Jin
No Relationships to Disclose
 
Huan Zhou
No Relationships to Disclose
 
Xinshuai Wang
No Relationships to Disclose
 
Yuee Teng
No Relationships to Disclose
 
Yongsheng Wang
No Relationships to Disclose
 
Qi Dang
No Relationships to Disclose
 
Jin Yang
Research Funding - AstraZeneca (Inst); Chia Tai Tianqing Pharmaceutical Group (Inst); CSPC Ouyi Pharmaceutical Co. (Inst); CSPC ZhongQi Pharmaceutical Technology (Inst); Jiangsu Hengrui Pharmaceuticals (Inst); Kelun Pharmaceuticals/Klus Pharma (Inst); MSD/Merck (Inst); RemeGen (Inst); Roche (Inst); SunCadia Bio (Inst)
 
Hui Hua Xiong
No Relationships to Disclose
 
Weihong Zhao
No Relationships to Disclose
 
Li Cai
No Relationships to Disclose
 
Tingting Fu
Employment - Suzhou Zanrong Pharma
 
Di Zhu
Employment - Suzhou Zanrong Pharma